Equipoise in Management of Patients With Acute Symptomatic Carotid Stenosis (Hot Carotid)

Overview

Journal Neurol Clin Pract

Date 2021 May 10

PMID 33968469

Citations 1

Authors

Aravind Ganesh

Luca Bartolini

Ravinder-Jeet Singh

Abdulaziz S Al-Sultan

David J T Campbell

John H Wong

Bijoy K Menon

Affiliations

Soon will be listed here.

Abstract

Objective: To explore differences in antithrombotic management of patients with acutely symptomatic carotid stenosis ("hot carotid") awaiting revascularization with endarterectomy or stenting (CEA/CAS).

Methods: We used a worldwide electronic survey with practice-related questions and clinical questions about 3 representative scenarios. Respondents chose their preferred antithrombotic regimen (1) in general, (2) if the patient was already on aspirin, or (3) had associated intraluminal thrombus (ILT) and identified clinical/imaging factors that increased or decreased their enthusiasm for additional antithrombotic agents. Responses among different groups were compared using multivariable logistic regression.

Results: We received 668 responses from 71 countries. The majority favored CT angiography (70.2%) to evaluate carotid stenosis, CEA (69.1%) over CAS, an aspirin-containing regimen (88.5%), and a clopidogrel-containing regimen (64.4%) if already on aspirin. Whereas diverse antithrombotic regimens were chosen, monotherapy was favored by 54.4%-70.6% of respondents across 3 scenarios. The preferred dual therapy was low-dose aspirin (75-100 mg) plus clopidogrel (22.2%) or high-dose aspirin (160-325 mg) plus clopidogrel if already on aspirin (12.2%). Respondents favoring CAS more often chose ≥2 agents (adjusted odds ratio [aOR] vs CEA: 2.00, 95% confidence interval 1.36-2.95, = 0.001) or clopidogrel-containing regimens (aOR: 1.77, 1.16-2.70, = 0.008). Regional differences included respondents from Europe less commonly choosing multiple agents if already on aspirin (aOR vs United States/Canada: 0.57, 0.35-0.93, = 0.023), those from Asia more often favoring multiple agents (aOR: 1.95, 1.11-3.43, = 0.020), vs those from the United States/Canada preferentially choosing heparin-containing regimens with ILT (aOR vs rest: 3.35, 2.23-5.03, < 0.001). Factors increasing enthusiasm for ≥2 antithrombotics included multiple TIAs (57.2%), ILT (58.5%), and ulcerated plaque (57.4%); 56.3% identified MRI microbleeds as decreasing enthusiasm.

Conclusions: Our results highlight the heterogeneous management and community equipoise surrounding optimal antithrombotic regimens for hot carotids.

Citing Articles

Picking Brains on a Global Scale: Practice Current and Practice Buzz.

Vera A, Bartolini L, Ganesh A Neurol Clin Pract. 2022; 12(4):e33-e34.

PMID: 36382114 PMC: 9647814. DOI: 10.1212/CPJ.0000000000200062.

References

Alcocer F, Novak Z, Combs B, Lowman B, Passman M, Mujib M . Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease. J Vasc Surg. 2014; 59(4):950-5. DOI: 10.1016/j.jvs.2013.10.087. View

Rothwell P, Eliasziw M, Gutnikov S, Fox A, Taylor D, Mayberg M . Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003; 361(9352):107-16. DOI: 10.1016/s0140-6736(03)12228-3. View

Puetz V, Dzialowski I, Coutts S, Hill M, Krol A, OReilly C . Frequency and clinical course of stroke and transient ischemic attack patients with intracranial nonocclusive thrombus on computed tomographic angiography. Stroke. 2008; 40(1):193-9. DOI: 10.1161/STROKEAHA.108.526277. View

Johansson E, Cuadrado-Godia E, Hayden D, Bjellerup J, Ois A, Roquer J . Recurrent stroke in symptomatic carotid stenosis awaiting revascularization: A pooled analysis. Neurology. 2016; 86(6):498-504. DOI: 10.1212/WNL.0000000000002354. View

Reznik M, Kamel H, Gialdini G, Pandya A, Navi B, Gupta A . Timing of Carotid Revascularization Procedures After Ischemic Stroke. Stroke. 2016; 48(1):225-228. PMC: 5183494. DOI: 10.1161/STROKEAHA.116.015766. View

Hlavica M, Berberat J, Ineichen B, Anon J, Diepers M, Nedeltchev K . Emergent vs. elective stenting of carotid stenosis with intraluminal carotid thrombus. J Neuroradiol. 2017; 44(4):254-261. DOI: 10.1016/j.neurad.2017.02.004. View

Barnett H, Gunton R, Eliasziw M, Fleming L, Sharpe B, Gates P . Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA. 2000; 283(11):1429-36. DOI: 10.1001/jama.283.11.1429. View

Petty G, Brown Jr R, Whisnant J, Sicks J, OFallon W, Wiebers D . Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999; 30(12):2513-6. DOI: 10.1161/01.str.30.12.2513. View

Zhang L, Zhao Z, Ouyang Y, Bao J, Lu Q, Feng R . Systematic Review and Meta-Analysis of Carotid Artery Stenting Versus Endarterectomy for Carotid Stenosis: A Chronological and Worldwide Study. Medicine (Baltimore). 2015; 94(26):e1060. PMC: 4504641. DOI: 10.1097/MD.0000000000001060. View

10.

Rothwell P . Prediction and prevention of stroke in patients with symptomatic carotid stenosis: the high-risk period and the high-risk patient. Eur J Vasc Endovasc Surg. 2008; 35(3):255-63. DOI: 10.1016/j.ejvs.2007.11.006. View

11.

Dalainas I, Nano G, Bianchi P, Stegher S, Malacrida G, Tealdi D . Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting. Cardiovasc Intervent Radiol. 2006; 29(4):519-21. DOI: 10.1007/s00270-005-5288-y. View

12.

Anand S, Bosch J, Eikelboom J, Connolly S, Diaz R, Widimsky P . Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 391(10117):219-229. DOI: 10.1016/S0140-6736(17)32409-1. View

13.

Gaba K, Syed M, Raza Z . Reducing the delay for carotid endarterectomy in South-East Scotland. Surgeon. 2013; 12(1):11-6. DOI: 10.1016/j.surge.2013.09.008. View

14.

Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C . Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013; 369(1):11-9. DOI: 10.1056/NEJMoa1215340. View

15.

Liu L, Wong K, Leng X, Pu Y, Wang Y, Jing J . Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Neurology. 2015; 85(13):1154-62. PMC: 4603889. DOI: 10.1212/WNL.0000000000001972. View

16.

Illuminati G, Schneider F, Pizzardi G, Masci F, Calio F, Ricco J . Dual Antiplatelet Therapy Does Not Increase the Risk of Bleeding After Carotid Endarterectomy: Results of a Prospective Study. Ann Vasc Surg. 2017; 40:39-43. DOI: 10.1016/j.avsg.2016.09.012. View

17.

Barkat M, Hajibandeh S, Torella F, Antoniou G . Systematic Review and Meta-analysis of Dual Versus Single Antiplatelet Therapy in Carotid Interventions. Eur J Vasc Endovasc Surg. 2016; 53(1):53-67. DOI: 10.1016/j.ejvs.2016.10.011. View

18.

den Hartog A, Moll F, van der Worp H, Hoff R, Kappelle L, de Borst G . Delay to carotid endarterectomy in patients with symptomatic carotid artery stenosis. Eur J Vasc Endovasc Surg. 2014; 47(3):233-9. DOI: 10.1016/j.ejvs.2013.12.013. View

19.

Lovett J, Coull A, Rothwell P . Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology. 2004; 62(4):569-73. DOI: 10.1212/01.wnl.0000110311.09970.83. View

20.

Amarenco P, Albers G, Denison H, Easton J, Evans S, Held P . Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol. 2017; 16(4):301-310. DOI: 10.1016/S1474-4422(17)30038-8. View